Very interesting. I think it’s a general trend that large acquisitive companies stop innovating themselves and it’s up to startups to shake things up. We’ve seen similar trend in pharma where the Pfizers of the world don’t come out with any new drugs and the innovation comes from the biotech startups that they later acquire.